19.50
前日終値:
$18.98
開ける:
$18.96
24時間の取引高:
180.94K
Relative Volume:
0.56
時価総額:
$601.08M
収益:
$4.12M
当期純損益:
$-56.68M
株価収益率:
-3.518
EPS:
-5.5429
ネットキャッシュフロー:
$-51.44M
1週間 パフォーマンス:
+25.00%
1か月 パフォーマンス:
-11.24%
6か月 パフォーマンス:
-30.43%
1年 パフォーマンス:
-16.45%
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
DNTH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
DNTH
Dianthus Therapeutics Inc
|
19.50 | 601.08M | 4.12M | -56.68M | -51.44M | -5.5429 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-20 | 開始されました | TD Cowen | Buy |
2024-10-03 | 開始されました | Oppenheimer | Outperform |
2024-07-26 | 開始されました | Robert W. Baird | Outperform |
2024-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
2024-05-16 | 開始されました | H.C. Wainwright | Buy |
2024-02-15 | 開始されました | Stifel | Buy |
2023-12-26 | 開始されました | Jefferies | Buy |
2023-11-22 | 開始されました | Wedbush | Outperform |
2023-10-30 | 開始されました | Guggenheim | Buy |
2023-09-28 | 開始されました | Raymond James | Outperform |
2022-08-25 | ダウングレード | Goldman | Buy → Neutral |
2022-01-06 | アップグレード | Goldman | Neutral → Buy |
2021-08-20 | 再開されました | Goldman | Neutral |
2021-08-03 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-07-22 | 繰り返されました | B. Riley Securities | Buy |
2021-06-29 | 開始されました | Cantor Fitzgerald | Overweight |
2021-06-15 | 開始されました | BTIG Research | Buy |
2021-05-18 | 開始されました | B. Riley Securities | Buy |
2021-01-07 | 開始されました | Mizuho | Buy |
2020-06-08 | アップグレード | Goldman | Neutral → Buy |
2019-03-25 | ダウングレード | Goldman | Buy → Neutral |
2019-03-15 | 開始されました | Raymond James | Outperform |
すべてを表示
Dianthus Therapeutics Inc (DNTH) 最新ニュース
Fmr LLC Has $96.78 Million Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Vanguard Group Inc. Sells 20,331 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Wellington Management Group LLP Boosts Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
KLP Kapitalforvaltning AS Acquires New Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by Corebridge Financial Inc. - Defense World
ADAR1 Capital Management LLC Has $385,000 Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Alliancebernstein L.P. - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World
Brokerages Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Target Price at $54.33 - MarketBeat
Rhenman & Partners Asset Management AB Sells 36,000 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (DNTH) Soars 6.1%: Is Further Upside Left in the Stock? - MSN
Dianthus Therapeutics (NASDAQ:DNTH) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Average Rating of “Buy” from Brokerages - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Hits New 12-Month LowShould You Sell? - MarketBeat
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 7%Here's What Happened - MarketBeat
DNTH Stock Touches 52-Week Low at $16.32 Amid Market Challenges - Investing.com UK
Swiss National Bank Sells 2,900 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Trading 6.5% HigherStill a Buy? - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Reaches New 52-Week LowWhat's Next? - MarketBeat
Charles Schwab Investment Management Inc. Acquires 1,092 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Deep Track Capital, LP Acquires Significant Stake in Dianthus Th - GuruFocus
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 3.8%Here's What Happened - MarketBeat
Avidity Partners Management LP Increases Stake in Dianthus Thera - GuruFocus
Cantor Fitzgerald Issues Positive Estimate for DNTH Earnings - MarketBeat
HC Wainwright Brokers Raise Earnings Estimates for DNTH - MarketBeat
FY2025 Earnings Forecast for DNTH Issued By Lifesci Capital - MarketBeat
Wedbush Equities Analysts Reduce Earnings Estimates for DNTH - MarketBeat
FY2025 EPS Estimates for DNTH Raised by Cantor Fitzgerald - Defense World
HC Wainwright Reaffirms "Buy" Rating for Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
HC Wainwright Issues Optimistic Outlook for DNTH Earnings - Defense World
Dianthus Therapeutics' (DNTH) Outperform Rating Reiterated at Wedbush - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap DownWhat's Next? - MarketBeat
Dianthus Therapeutics (DNTH) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Dianthus Therapeutics Inc (DNTH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):